749775
Last Update Posted: 2020-12-22
Recruiting has ended
All Genders accepted | Under |
3338 Estimated Participants | No Expanded Access |
Observational Study | Does not accept healthy volunteers |
Selara Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
To collect the efficacy and safety information of Eplerenone on patients with hypertension related to their appropriate use in daily practice.
Eligibility
Relevant conditions:
Hypertension
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov